The α2A-adrenergic receptor (ADRA2A) modulates susceptibility to Raynaud’s syndrome

Anniina Tervi, Markus Ramste, Erik Abner, Paul Cheng, Jacqueline M. Lane, Matthew Maher, Vilma Lammi, Satu Strausz, Trieu Nguyen, Mauro Lago Docampo, Wenduo Gu, FinnGen, Estonian biobank research team, Tõnu Esko, Richa Saxena, Aarno Palotie, Samuli Ripatti, Nasa Sinnott-Armstrong, Mark Daly, Marlene Rabinovitch, Caroline A. Heckman, Thomas Quertermous, Samuel E. Jones, Hanna M. Ollila
doi: https://doi.org/10.1101/2023.10.04.23296526

Article Information

doi 
https://doi.org/10.1101/2023.10.04.23296526
History 
  • October 12, 2023.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Anniina Tervi1,*,†,
  2. Markus Ramste2,*,
  3. Erik Abner3,
  4. Paul Cheng2,
  5. Jacqueline M. Lane4,5,6,
  6. Matthew Maher5,
  7. Vilma Lammi1,
  8. Satu Strausz1,
  9. Trieu Nguyen2,
  10. Mauro Lago Docampo8,14,
  11. Wenduo Gu2,
  12. FinnGen, Estonian biobank research team,
  13. Tõnu Esko3,
  14. Richa Saxena5,6,7,
  15. Aarno Palotie1,9,10,11,
  16. Samuli Ripatti1,5,12,
  17. Nasa Sinnott-Armstrong13,
  18. Mark Daly1,9,10,11,
  19. Marlene Rabinovitch14,
  20. Caroline A. Heckman1,
  21. Thomas Quertermous2,
  22. Samuel E. Jones1 and
  23. Hanna M. Ollila1,5,6,7,†
  1. 1Institute for Molecular Medicine Finland FIMM, Helsinki Institute of Life Science - HiLIFE, University of Helsinki, Helsinki, Finland
  2. 2Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305
  3. 3Institute of Genomics, University of Tartu, Tartu, Estonia
  4. 4Division of Sleep and Circadian Disorders, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
  5. 5Broad Institute of MIT and Harvard, Cambridge, MA, USA
  6. 6Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
  7. 7Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  8. 8Stanford Cardiovascular Institute, Stanford University School of Medicine, CA
  9. 9Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
  10. 10Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA
  11. 11Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
  12. 12Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland
  13. 13Herbold Computational Biology Program, Public Health Sciences Division, Fred Hutch, Seattle, WA, USA
  14. 14Stanford Children’s Health Betty Irene Moore Children’s Heart Center, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA
  1. ↵†Correspondence: anniina.tervi{at}helsinki.fi; hanna.m.ollila{at}helsinki.fi

  1. ↵* Equal contribution

Back to top
Posted October 12, 2023.
Download PDF

Supplementary Material

Data/Code
Email
The α2A-adrenergic receptor (ADRA2A) modulates susceptibility to Raynaud’s syndrome
Anniina Tervi, Markus Ramste, Erik Abner, Paul Cheng, Jacqueline M. Lane, Matthew Maher, Vilma Lammi, Satu Strausz, Trieu Nguyen, Mauro Lago Docampo, Wenduo Gu, FinnGen, Estonian biobank research team, Tõnu Esko, Richa Saxena, Aarno Palotie, Samuli Ripatti, Nasa Sinnott-Armstrong, Mark Daly, Marlene Rabinovitch, Caroline A. Heckman, Thomas Quertermous, Samuel E. Jones, Hanna M. Ollila
medRxiv 2023.10.04.23296526; doi: https://doi.org/10.1101/2023.10.04.23296526
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area